Nova Insilico

Nova accelerate and de-risk clinical trials with digital evidence

Nova provides its Jinkō® clinical trials simulation platform to BioTech and pharma companies, academic research centers and non-profit organizations.

Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials.

</aside>

Type

Concept

Concept

Service

Branding

Branding

Sector

BioTech

BioTech

Year

2024

2024

Challenge

Challenge

Create a brand identity that seamlessly blends simplicity and emotion for a cutting-edge biotech company

The challenge lies in crafting a visual identity and messaging that effectively communicates the company's complex scientific foundations while maintaining an approachable and emotive appeal. This brand should not only reflect the company's technological prowess but also its commitment to improving human health through innovative solutions.